Summary of US FDA GRAS Acceptance and Approval Status in the Third Quarter of 2024

In the third quarter of 2024, the FDA's official website updated the Generally Recognized as Safe (GRAS) status of 13 products. All of them are still under review.

This article provides a summary of the US FDA GRAS acceptance and approval status in the third quarter of 2024, for the information and reference of businesses.

Pending substances in the third quarter of 2024

S.N.	GRN No.	Substance	Notifier
1	1182	Hydroxytyrosol	Hangzhou Viablife Biotech Co, Ltd. (China)
2	1183	Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)	Oobli, Inc. (U.S.)
3	1184	Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)	Sichuan Ingia Biosynthetic Co., Ltd.（China）
4	1185	Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3	Runke Bioengineering (Fujian) Co., Ltd. (China)
5	1186	Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01	Runke Bioengineering (Fujian) Co., Ltd. (China)
6	1187	Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding polygalacturonase from Aspergillus luchuensis mut kawachii	AB Enzymes, Inc. (U.S.)
7	1188	D-psicose	Shandong Starlight So True Biological Technology Co., Ltd (China)
8	1189	Dry whole goat milk	Bubs Australia Limited (U.S.)
9	1190	Saccharomyces cerevisiae strain OYR-481 expressing a gene encoding acetolactate decarboxylase from Brevibacillus brevis	Omega Yeast Labs, LLC (U.S.)
10	1191	Ergothioneine produced by Escherichia coli BL-21 (DE3) expressing ergothioneine synthases from Schizosaccharomyces pombe	Shanghai EGT Synbio Group Co., LTD (China)
11	1192	Tannase enzyme preparation produced by Aspergillus oryzae	Mitsubishi Chemical Corporation (Japan)
12	1193	D-psicose	Sichuan Ingia Biosynthetic Co., Ltd. (China)
13	1194	Partially hydrolyzed eggshell membrane powder derived from chicken eggs	ESM Technologies, LLC (U.S.)

Source: The inventory of GRAS notices.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

Summary of US FDA GRAS Acceptance and Approval Status in the First Quarter of 2024

Summary of US FDA GRAS Acceptance and Approval Status in the Second Quarter of 2024

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.